Patients with heterozygous mutations are associated with autosomal dominant LQTS (Romano–Ward syndrome) whereas patients with homozygous or compound heterozygous KCNQ1 mutations have a more severe clinical outcome and are associated with recessive LQTS (Jervell–Lange–Nielsen syndrome)[33]. This evidence concerns the gene KCNQ1 and familial long QT syndrome.